bluebird bio CEO Nick Leschly's 2018 pay jumps 173% to $24M
bluebird bio reports 2018 executive compensation
By ExecPay News
Published: April 23, 2019
bluebird bio reported fiscal year 2018 executive compensation information on April 23, 2019.
In 2018, five executives at bluebird bio received on average a compensation package of $11M, a 154% increase compared to previous year.
Average pay of disclosed executives at bluebird bio
Nick Leschly, Chief Executive Officer, received $24M in total, which increased by 173% compared to 2017. 70% of Leschly's compensation, or $17M, was in option awards. Leschly also received $466K in non-equity incentive plan, $610K in salary, $6.2M in stock awards, as well as $9.3K in other compensation.
Jeffrey T. Walsh, Chief Strategy Officer, received a compensation package of $9.3M, which increased by 93% compared to previous year. 68% of the compensation package, or $6.3M, was in option awards.
David Davidson, Chief Medical Officer, earned $9.3M in 2018, a 204% increase compared to previous year.
Philip D. Gregory, Chief Scientific Officer, received $8.7M in 2018, which increases by 186% compared to 2017.
Jason F. Cole, Chief Operating and Legal Officer, earned $5.4M in 2018, a 108% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 23, 2019.